Analysis of Cytotoxic T Cell Responses to Dominant and Subdominant Epitopes during Acute and Chronic Lymphocytic Choriomeningitis Virus Infection

Journal of Immunology

Volumn 157, Issue 12, 1996, Pages 5543-5554

  Van Der Most, Robbert G ^b,d   Sette, Alessandro ^c   Oseroff, Carla ^c   Alexander, Jeff ^c   Murali Krishna, Kaja ^a   Lau, Lisa L ^b   Southwood, Scott ^c   Sidney, John ^c   Chesnut, Robert W ^c   Matloubian, Mehrdad ^b   Ahmed, Rafi ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c CYTEL CORPORATION   (United States)

^d CALIFORNIA INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; H2 ANTIGEN; PEPTIDE; RECOMBINANT VACCINE; VIRUS ANTIGEN; VIRUS PROTEIN; VIRUS VACCINE;

ACUTE DISEASE; ANIMAL; ARTICLE; BAGG ALBINO MOUSE; CELLULAR IMMUNITY; CHEMISTRY; CHRONIC DISEASE; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; IMMUNOLOGY; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MOUSE; VIRUS MENINGITIS;

ACUTE DISEASE; ANIMALS; ANTIGENS, VIRAL; CHRONIC DISEASE; CYTOTOXICITY, IMMUNOLOGIC; H-2 ANTIGENS; IMMUNITY, CELLULAR; IMMUNODOMINANT EPITOPES; LYMPHOCYTIC CHORIOMENINGITIS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MICE; MICE, INBRED BALB C; PEPTIDES; T-LYMPHOCYTES, CYTOTOXIC; VACCINES, SYNTHETIC; VIRAL PROTEINS; VIRAL VACCINES;

EID: 0030589236     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (82)

1. b molecule. Nature 348:213.
2. Schumacher, T. N. M., M. L. H. De Bruijn, L. N. Vernie, W. M. Kast, C. J. M. Melief, J. J. Neefjes, and H. L. Ploegh. 1991. Peptide selection by MHC class I molecules. Nature 350:703.
3. Townsend, A. R. M., and H. Bodmer. 1989. Antigen recognition by class I-restricted T lymphocytes. Annu. Rev. Immunol. 7:601.
4. Falk, K., O. Rotzschke, S. Stevanovic, G. Jung, and H.-G. Rammensee. 1991. Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature 351:290.
5. Rotzschke, O., K. Falk, K. Deres, H. Schild, M. Norda, J. Metzger, G. Jung, and H.-G. Rammensee. 1990. Isolation and analysis of naturally processed peptides as recognized by cytotoxic T cells. Nature 348:252.
6. d exploits a four-residue peptide-binding motif. J. Exp. Med. 178:1877.
7. Rammensee, H.-G., T. Friede, and S. Stevanovic. 1995. MHC ligands and peptide motifs: first listing. Immunogenetics 41:178.
8. Carbone, F. R., and M. J. Bevan. 1989. Induction of ovalbumin-specific cytotoxic T cells by in vivo peptide immunization. J. Exp. Med. 169:603.
9. Aichele, P., H. Herngartner, and M. Zinkernagel. 1990. Antiviral cytotoxic T cell response induced by in vivo priming with a free synthetic peptide. J. Exp. Med. 171:1815.
10. Kast, W. M., L. Roux, J. Curren, H. J. J. Blom, A. C. Voordouw, R. H. Meloen, D. Kolakofsky, and C. J. M. Melief. 1991. Protection against lethal Sendai virus infection by in vivo priming of virus-specific cytotoxic T lymphocytes with a free synthetic peptide. Proc. Natl. Acad. Sci. USA 88:2283.
11. Brown, F. 1990. The potential of peptides as vaccines. Semin. Virol. 1:67.
12. Schulz, M., R. M. Zinkernagel, and H. Herngartner. 1991. Peptide-induced antiviral protection by cytotoxic T-cells. Proc. Natl. Acad. Sci. USA 88:991.
13. Barber, L. D., and P. Parham. 1994. The essence of epitopes. J. Exp. Med. 180:1191.
14. Sette, A., A. Vitiello, B. Reherman, P. Fowler, R. Nayersina, W. M. Kast, C. J. M. Melief, C. Oseroff, L. Yuan, J. Ruppert, J. Sidney, M.-F. Del Guercio, S. Southwood, R. T. Kubo, R. W. Chesnut, H. M. Grey, and F. V. Chisari. 1994. The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes. J. Immunol. 153:5586.
15. Feltkamp, M. C. W., M. P. M. Vierboom, W. M. Kast, and C. J. M. Melief. 1994. Efficient MHC class I-peptide binding is required but does not ensure MHC class I-restricted immunogenicity. Mol. Immunol. 31:1391.
16. Chen, W., S. Khilko, J. Fecondo, D. H. Margulies, and J. McCluskey. 1994. Determinant selection of major histocompatibility complex class I-restricted antigenic peptides is explained by class I-peptide affinity and is strongly influenced by nondominant anchor residues. J. Exp. Med. 180:1471.
17. Ruppert, J., J. Sidney, E. Calls, R. T. Kubo, H. M. Grey, and A. Sette. 1993. Prominent role of secondary anchor residues in peptide binding to HLA-A2.1 molecules. Cell 74:929.
18. Sadovnikova, E., X. Zhu, S. M. Collins, J. Zhou, K. Vousden, L. Crawford, P. Beverley, and H. J. Stauss. 1994. Limitations of predictive motifs revealed by cytotoxic T lymphocyte epitope mapping of the human papilloma virus E7 protein. Int. Immunol. 6:289.
19. b cells. J. Immunol. 152:4843.
20. d-restricted ovalbumin peptide and an assessment of the predictive power of MHC-binding motifs. Eur. J. Immunol. 22:2663.
21. Moore, M. W., F. R. Carbone, and M. J. Bevan. 1988. Introduction of soluble protein into the class I pathway of antigen processing and presentation. Cell 54:777.
22. Rotzschke, O., K. Falk, S. Stevanovic, G. Jung, P. Walden, and H.-G. Rammensee. 1991. Exact prediction of a natural T cell epitope. Eur. J. Immunol. 21:2891.
23. Ahmed, R., B. Jamieson, and D. D. Porter. 1987. Immune therapy of a persistent and disseminated viral infection. J. Virol. 61:3920.
24. Byrne, J. A., and M. B. A. Oldstone. 1984. Biology of cloned cytotoxic T lymphocytes specific for lymphocytic choriomeningitis virus: clearance of virus in vivo. J. Virol. 51:682.
25. + T cells and nonspecific bone marrow-derived cells. J. Virol. 61:3930.
26. + T lymphocytes mediate clearance of virus and regulate the antiviral antibody response. J. Virol. 61:1867.
27. Whitton, J., A. Tishon, H. Lewicki, J. Gephard, T. Cook, M. Salvato, E. Joly, and M. Oldstone. 1989. Molecular analysis of a five amino acid cytotoxic T-lymphocyte (CTL) epitope: an immunodominant region which induces nonreciprocal CTL cross-reactivity. J. Virol. 63:4303.
28. Schulz, M., P. Aichele, R. Schneider, T. H. Hansen, R. M. Zinkernagel, and H. Herngartner. 1991. Major histocompatibility complex binding and T-cell recognition of a viral nonapeptide containing a minimal tetrapeptide. Eur. J. Immunol. 21:1181.
29. Lewicki, H. A., M. G. Von Herrath, C. F. Evans, J. L. Whitton, and M. B. A. Oldstone. 1995. CTL escape variants. II. Biological activity in vivo. Virology 211:443.
30. Hany, M., S. Oehen, M. Schultz, H. Hergartner, M. Mackett, D. H. L. Bishop, and R. M. Zinkernagel. 1989. Anti-viral protection and prevention of lymphocytic choriomeningitis or of the local footpad swelling reaction in mice by immunization with vaccinia-recombinant virus expressing LCMV-WE nucleoprotein or glycoprotein. Eur. J. Immunol. 19:417.
31. Von Herrath, M. G., J. Dockter, M. Nerenberg, J. E. Gairin, and M. B. A. Oldstone. 1994. Thymic selection and adaptability of cytotoxic T lymphocyte responses in transgenic mice expressing a viral protein in the thymus. J. Exp. Med. 180:1901.
32. Oldstone, M. B. A., H. Lewicki, P. Borrow, D. Hudrisier, and J. E. Gairin. 1995. Discriminated selection among viral peptides with the appropriate anchor residues: implications for the size of the cytotoxic T-lymphocyte repertoire and control of viral infection. J. Virol. 69:7423.
33. + T lymphocyte-mediated antiviral immunity in mice as a result of injection of recombinant viral proteins. J. Immunol. 153:2554.
34. Ahmed, R., A. Salmi, L. D. Butler, J. Chiller, and M. B. A. Oldstone. 1984. Selection of genetic variants of lymphocytic choriomeningitis virus in spleens of persistently infected mice: role in suppression of cytotoxic T lymphocyte response and viral persistence. J. Virol. 62:521.
35. King, C. C., R. de Fries, S. R. Kolhekar, and R. Ahmed. 1990. In vivo selection of lymphocyte-tropic and macrophage-tropic variants of lymphocytic choriomeningitis virus during persistent infection. J. Virol. 64:5611.
36. Ahmed, R., C. S. Hahn, T. Somasundaram, L. Villarete, M. Matloubian, and J. H. Strauss. 1991. Molecular basis of organ-specific selection of viral variants during chronic infection. J. Virol. 65:4242.
37. Matloubian, M., S. R. Kolhekar, T. Somasundaram, and R. Ahmed. 1993. Molecular determinants of macrophage tropism and viral persistence: importance of single amino acid changes in the polymerase and glycoprotein of lymphocytic choriomeningitis virus. J. Virol. 67:7340.
38. Sidney, J., M.-F. del Guercio, S. Southwood, V. H. Engelhard, E. Appella, H.-G. Rammensee, K. Falk, O. Rotzschke, M. Takiguchi, R. T. Kubo, H. M. Grey, and A. Sette. 1995. Several HLA alleles share overlapping peptide specificities. J. Immunol. 154:247.
39. Sette, A., J. Sidney, M.-F. Del Guercio, S. Southwood, J. Ruppert, C. Dahlberg, H. M. Grey, and R. T. Tubo. 1994. Peptide binding to the most frequent HLA-A class I alleles measured by quantitative molecular binding assays. Mol. Immunol. 31:813.
40. Kubo, R. T., A. Sette, H. M. Grey, E. Appella, K. Sakaguchi, N. Z. Zhu, D. Arnott, N. Sherman, J. Shabanowitz, H. Michel, W. M. Bodnar, T. A. Davis, and D. F. Hunt. 1994. Definition of specific peptide motifs for four major HLA-A alleles. J. Immunol. 152:3913.
41. Kast, W. M., R. M. P. Brandt, J. Sidney, J.-W. Drijfhout, R. T. Kubo, H. M. Grey, C. J. M. Melief, and A. Sette. 1994. The role of HLA-A motifs in identification of potential CTL epitopes in human papillomavirus type 16 E6 and E7 proteins. J. Immunol. 152:3904.
42. 131I-labeled human growth factor hormone of high specific radioactivity. Biochem. J. 89:114.
43. Vitiello, A., G. Ishioka, H. M. Grey, R. Rose, P. Farness, R. LaFond, L. Yuan, F. V. Chisari, J. Furze, R. Bartholomeuz, and R. W. Chesnut. 1995. Development of a lipopeptide-based therapeutic vaccine to treat chronic HBV infection. I. Induction of a primary cytotoxic T lymphocyte response in humans. J. Clin. Invest. 95:341.
44. Townsend, A. R., J. Rothbard, F. M. Gotch, G. Bahadur, D. Wraith, and A. J. McMichael. 1986. The epitopes of influenza virus nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides. Cell 44:959.
45. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156.
46. Hamlyn, P., M. J. Gait, and C. Milstein. 1981. Complete sequence of an immunoglobulin mRNA using specific priming and the dideoxynucleotide method of RNA sequencing. Nucleic Acids Res. 9:4485.
47. Takahashi, H., J. Cohen, A. Hosmalin, K. B. Cease, R. Houghten, J. Cornette, C. DeLisi, B. Moss, R. N. Germain, and J. A. Berzofsky. 1988. An immunodominant epitope of the HIV gp 160 envelope glycoprotein recognized by class I MHC molecule-restricted murine cytotoxic T lymphocytes. Proc. Natl. Acad. Sci. USA 81:3105.
48. Shirai, M., C. D. Pendleton, and J. A. Berzofsky. 1992. Broad recognition of cytotoxic T cell epitopes from the HIV-1 envelope protein with multiple class I histocompatibility molecules. J. Immunol. 148:1657.
49. Bergmann, C., S. A. Stohlmann, and M. McMillan. 1993. An endogenously synthesized decamer peptide efficiently primes cytotoxic T cells specific for the HIV-1 envelope glycoprotein. Eur. J. Immunol. 23:2777.
50. Corr, M., L. F. Boyd, S. R. Frankel, S. Kozlowski, E. A. Padlan, and D. H. Margulies. 1992. Endogenous peptides of a soluble major histocompatibility complex class-I molecule, H-2L(D)(S) - sequence motif, quantitative binding, and molecular modelling of the complex. J. Exp. Med. 176:1681.
51. Chen, Y., J. Sidney, S. Southwood, A. L. Cox, K. Sakaguchi, R. A. Henderson, E. Appella, D. F. Hunt, A. Sette, and V. H. Engelhard. 1994. Naturally processed peptides longer than 9 amino acid residues bind to the class I MHC molecule HLA-A2.1 with high affinity and in different conformations. J. Immunol. 152:2874.
52. Ahmed, R., and M. B. A. Oldstone. 1988. Organ-specific selection of viral variants during chronic infection. J. Exp. Med. 167:1719.
53. Moskophides, D., F. Lechner, H. Pircher, and R. M. Zinkernagel. 1993. Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cycotoxic effector cells. Nature 362:758.
54. Tishon, A., P. Borrow, C. Evans, and M. B. A. Oldstone. 1993. Virus-induced immune suppression. 1. Age at infection relates to a selective or generalized effect. Virology 195:397.
55. Borrow, P., C. F. Evans, and M. B. A. Oldstone. 1995. Virus-induced immunosuppression - immune system-mediated destruction of virus-infected dendritic cells results in generalized immune suppression. J. Virol. 69:1059.
56. Odermatt, B., M. Eppler, T. P. Leist, H. Hengartner, and R. M. Zinkernagel. 1991. Virus-triggered acquired immunodeficiency by cytotoxic T-cell-dependent destruction of antigen-presenting cells and lymph follicle structure. Proc. Natl. Acad. Sci. USA 88:8252.
57. Althage, A., B. Odermatt, D. Moskophides, T. Kundig, H. Hengartner, and R. M. Zinkernagel. 1992. Immunosuppression by lymphocytic choriomeningitis virus infection: competent effector T and B cells but impaired antigen presentation. Eur. J. Immunol. 22:1803.
58. Hotchin, J. 1971. Persistent and slow virus infections. Monogr. Virol. 3:1.
59. Lau, L., B. D. Jamieson, T. Somasundaram, and R. Ahmed. 1994. Cytotoxic T-cell memory without antigen. Nature 369:648.
60. Oldstone, M. B. A., A. Tishon, M. Eddleston, J. C. de la Torre, T. McKee, and J. L. Whitton. 1993. Vaccination to prevent persistent viral infection. J. Virol. 67:4372.
61. Niedermann, G., S. Butz, H. G. Ihlenfeld, R. Grimm, M. Lucchiari, H. Hoschutzky, G. Jung, B. Maier, and K. Eichmann. 1995. Contribution of proteasome-mediated proteolysis to the hierarchy of epitopes presented by major histocompatibility complex I molecules. Immunity 2:289.
62. Oldstone, M. B. A., J. L. Whitton, H. Lewicki, and A. Tishon. 1988. Fine dissection of a nine amino acid glycoprotein epitope, a major determinant recognized by lymphocytic choriomeningitis virus-specific class I-restricted H-2Db cytotoxic T lymphocytes. J. Exp. Med. 168:559.
63. b major histocompatibility complex class I molecules and presented to cytotoxic T lymphocytes. J. Virol. 69:2297.
64. Klavinskis, L. S., J. L. Whitton, E. Joly, and M. B. A. Oldstone. 1990. Vaccination and protection from a lethal viral infection: identification, incorporation, and use of a cytotoxic T lymphocyte glycoprotein epitope. Virology 178:393.
65. Whitton, J. L., N. Sheng, M. B. A. Oldstone, and T. A. McKee. 1993. A "string-of-beads" vaccine, comprising linked minigenes, confers protection from lethal-dose virus challenge. J. Virol. 67:348.
66. Johnson, R. P., A. Trocha, T. M. Buchanan, and B. D. Walker. 1992. Identification of overlapping HLA class I-restricted cytotoxic T cell epitopes in a conserved region of the human immunodeficiency virus type 1 envelope glycoprotein: definition of minimum epitopes and analysis of the effects of sequence variation. J. Exp. Med. 175:961.
67. Nixon, D. F., K. Broliden, G. Ogg, and P. A. Broliden. 1992. Cellular and humoral antigenic epitopes in HIV and SIV. Immunology 76:515.
68. Elliott, T., M. Smith, P. Driscoll, and A. McMichael. 1993. Peptide selection by class I molecules of the major histocompatibility complex. Curr. Biol. 3:854.
69. Tussey, L. G., S. Rowland-Jones, T. S. Zheng, M. J. Androlewicz, P. Cresswell, J. A. Frelinger, and A. J. McMichael. 1995. Different MHC class I alleles compete for presentation of overlapping viral epitopes. Immunity 3:65.
70. Weidt, G., W. Deppert, O. Utermohlen, J. Heukeshoven, and F. Lehmann-Grube. 1995. Emergence of virus escape mutants after immunization with epitope vaccine. J. Virol. 69:7147.
71. Braciale, T. J., M. T. Sweetser, L. A. Morrison, D. J. Kittlesen, and V. L. Braciale. 1989. Class-I major histocompatibility complex-restricted cytolytic T-lymphocytes recognize a limited number of sites on the influenza hemagglutinin. Proc. Natl. Acad. Sci. USA 86:277.
72. d-restricted antigenic peptides share a simple binding motif. J. Exp. Med. 174:603.
73. Widmann, C., P. Romero, J. L. Maryanski, G. Corradin, and D. Valmori. 1992. T helper epitopes enhance the cytotoxic response of mice immunized with MHC class I-restricted malaria peptides. J. Immunol. Methods 155:95.
74. Taylor, P. M., J. Davey, K. Howland, J. B. Rothbard, and B. A. Askonas. 1987. Class-I MHC molecules rather than other mouse genes dictate influenza epitope recognition by cytotoxic T-cells. Immunogenetics 26:267.
75. Pamer, E. G., J. T. Harty, and M. J. Bevan. 1991. Precise prediction of a dominant class-I MHC-restricted epitope of Listeria monocytogenes. Nature 353:852.
76. Casanova, J. L., F. Martinon, H. Gournier, C. Barra, C. Pannetier, A. Regnault, P. Kourilsky, J. C. Cerottini, and J. L. Maryanski. 1993. T cell receptor selection by and recognition of 2 class-I major histocompatibility complex-restricted antigenic peptides that differ at a single position. J. Exp. Med. 177:811.
77. Maryanski, J. L., P. Pala, J. C. Cerottini, and G. Corradin. 1988. Synthetic peptides as antigens and competitors in recognition by H-2-restricted cytolytic T-cells specific for HLA. J. Exp. Med. 167:1391.
78. Eberl, G., A. Sabbatini, C. Servis, P. Romero, J. L. Maryanski, and G. Corradin. 1993. MHC class-I H-2K(D)-restricted antigenic peptides - additional constraints for the binding motif. Int. Immunol. 5:1489.
79. d-restricted neo-antigen by a Tyr substitution. J. Exp. Med. 174:1657.
80. Ando, K., L. G. Guidotti, S. Wirth, T. Ishikawa, G. Missale, T. Moriyama, R. D. Schreiber, H. J. Schlicht, S. N. Huang, and F. V. Chisari. 1994. Class I-restricted cytotoxic T lymphocytes are directly cytopathic for their target cells in vivo. J. Immunol. 152:3245.
81. Reddehase, M. J., J. B. Rothbard, and U. H. Koszinowski. 1989. A pentapeptide as minimal antigenic determinant for MHC class-I restricted T-lymphocytes. Nature 337:651.
82. d class-I MHC molecule. Nature 344:439.